Since GSDMB expression promotes cell survival to anti-HER2 treatment, the analysis of GSDMB gene status and/or GSDMB expression may lead to more precise molecular classification of this cancer subtype and, in turn, help to identify cases that may not benefit from the current therapies. The gene discussed is ERBB2; the disease is cancer.